94 results
Page 4 of 5
6-K
EX-99.1
wb119e5xpn bs
19 Aug 20
Current report (foreign)
6:00am
6-K
EX-99.1
c51slf
13 Aug 20
Current report (foreign)
9:42am
6-K
EX-99.1
bg5gvpeip79tflk2x
24 Jul 20
Current report (foreign)
9:45am
6-K
EX-99.1
zcejgn flhsxo
8 Jun 20
Current report (foreign)
6:00am
6-K
EX-99.1
kamj09s4tr
4 Jun 20
Current report (foreign)
11:01am
6-K
EX-99.1
9fa2pirboe4qx0a
26 May 20
Gilead and Galapagos Announce Positive Topline Results of Phase 2B/3 Trial of Filgotinib In Moderately to Severely Active Ulcerative Colitis
6:10am
6-K
EX-99.1
5pga07msp wo
12 Nov 19
Current report (foreign)
6:15am
6-K
EX-99.1
tt4clkjbhqr98
11 Oct 19
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks In Finch 1 and Finch 3 Studies In Rheumatoid Arthritis
6:00am
6-K
EX-99.1
zsrj7lei 94og133
5 Sep 19
European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis
5:24pm
6-K
EX-99.1
9xkjerk h45s
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.4
q02ht
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.2
96ielw4
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.3
gf9 mj5can
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.1
9c2jbs42d789jhct2
15 Jul 19
Gilead and Galapagos Enter into Transformative Research and Development Collaboration
11:59am
6-K
EX-99.1
1hjdd05
31 May 19
Current report (foreign)
10:27am
F-3ASR
kqj5pqcgw6zy7k
29 Mar 19
Automatic shelf registration (foreign)
5:26pm
6-K
EX-99.1
i529u6l7
29 Mar 19
Current report (foreign)
6:16am
6-K
EX-99.1
uwr95ir
29 Mar 19
Current report (foreign)
6:02am